Literature DB >> 23970564

Cerebrospinal-fluid-derived immunoglobulin G of different multiple sclerosis patients shares mutated sequences in complementarity determining regions.

Vaibhav Singh1, Marcel P Stoop, Christoph Stingl, Ronald L Luitwieler, Lennard J Dekker, Martijn M van Duijn, Karim L Kreft, Theo M Luider, Rogier Q Hintzen.   

Abstract

B lymphocytes play a pivotal role in multiple sclerosis pathology, possibly via both antibody-dependent and -independent pathways. Intrathecal immunoglobulin G in multiple sclerosis is produced by clonally expanded B-cell populations. Recent studies indicate that the complementarity determining regions of immunoglobulins specific for certain antigens are frequently shared between different individuals. In this study, our main objective was to identify specific proteomic profiles of mutated complementarity determining regions of immunoglobulin G present in multiple sclerosis patients but absent in healthy controls. To achieve this objective, we purified immunoglobulin G from the cerebrospinal fluid of 29 multiple sclerosis patients and 30 healthy controls and separated the corresponding heavy and light chains via SDS-PAGE. Subsequently, bands were excised, trypsinized, and measured with high-resolution mass spectrometry. We sequenced 841 heavy and 771 light chain variable region peptides. We observed 24 heavy and 26 light chain complementarity determining regions that were solely present in a number of multiple sclerosis patients. Using stringent criteria for the identification of common peptides, we found five complementarity determining regions shared in three or more patients and not in controls. Interestingly, one complementarity determining region with a single mutation was found in six patients. Additionally, one other patient carrying a similar complementarity determining region with another mutation was observed. In addition, we found a skew in the κ-to-λ ratio and in the usage of certain variable heavy regions that was previously observed at the transcriptome level. At the protein level, cerebrospinal fluid immunoglobulin G shares common characteristics in the antigen binding region among different multiple sclerosis patients. The indication of a shared fingerprint may indicate common antigens for B-cell activation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23970564      PMCID: PMC3861734          DOI: 10.1074/mcp.M113.030346

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  37 in total

1.  Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid.

Authors:  Gregory P Owens; Alanna M Ritchie; Mark P Burgoon; R Anthony Williamson; John R Corboy; Donald H Gilden
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

2.  Secreted human Ro52 autoantibody proteomes express a restricted set of public clonotypes.

Authors:  Georgia Arentz; Lauren A Thurgood; Rhianna Lindop; Tim K Chataway; Tom P Gordon
Journal:  J Autoimmun       Date:  2012-08-05       Impact factor: 7.094

3.  Restricted use of VH4 germline segments in an acute multiple sclerosis brain.

Authors:  G P Owens; H Kraus; M P Burgoon; T Smith-Jensen; M E Devlin; D H Gilden
Journal:  Ann Neurol       Date:  1998-02       Impact factor: 10.422

Review 4.  The human immunoglobulin VH repertoire.

Authors:  G P Cook; I M Tomlinson
Journal:  Immunol Today       Date:  1995-05

5.  Multiple sclerosis: disturbed kappa: lambda chain ratio of immunoglobulin G in cerebrospinal fluid.

Authors:  H Link; O Zettervall
Journal:  Clin Exp Immunol       Date:  1970-03       Impact factor: 4.330

6.  Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients.

Authors:  M Colombo; M Dono; P Gazzola; S Roncella; A Valetto; N Chiorazzi; G L Mancardi; M Ferrarini
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

7.  Potassium channel KIR4.1 as an immune target in multiple sclerosis.

Authors:  Rajneesh Srivastava; Muhammad Aslam; Sudhakar Reddy Kalluri; Lucas Schirmer; Dorothea Buck; Björn Tackenberg; Veit Rothhammer; Andrew Chan; Ralf Gold; Achim Berthele; Jeffrey L Bennett; Thomas Korn; Bernhard Hemmer
Journal:  N Engl J Med       Date:  2012-07-12       Impact factor: 91.245

8.  Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

Authors:  Y Qin; P Duquette; Y Zhang; P Talbot; R Poole; J Antel
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

9.  Common T-cell receptor V beta usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis.

Authors:  S J Lee; K W Wucherpfennig; S A Brod; D Benjamin; H L Weiner; D A Hafler
Journal:  Ann Neurol       Date:  1991-01       Impact factor: 10.422

10.  Maintenance of B lymphocyte-related clones in the cerebrospinal fluid of multiple sclerosis patients.

Authors:  Monica Colombo; Mariella Dono; Paola Gazzola; Nicholas Chiorazzi; Gianluigi Mancardi; Manlio Ferrarini
Journal:  Eur J Immunol       Date:  2003-12       Impact factor: 5.532

View more
  14 in total

Review 1.  Proteomic Approaches to Decipher Mechanisms Underlying Pathogenesis in Multiple Sclerosis Patients.

Authors:  Vaibhav Singh; Ajai Tripathi; Ranjan Dutta
Journal:  Proteomics       Date:  2019-06-21       Impact factor: 3.984

Review 2.  A perspective toward mass spectrometry-based de novo sequencing of endogenous antibodies.

Authors:  Sebastiaan C de Graaf; Max Hoek; Sem Tamara; Albert J R Heck
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

3.  Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM.

Authors:  Tobias V Lanz; R Camille Brewer; Peggy P Ho; Jae-Seung Moon; Kevin M Jude; Daniel Fernandez; Ricardo A Fernandes; Alejandro M Gomez; Gabriel-Stefan Nadj; Christopher M Bartley; Ryan D Schubert; Isobel A Hawes; Sara E Vazquez; Manasi Iyer; J Bradley Zuchero; Bianca Teegen; Jeffrey E Dunn; Christopher B Lock; Lucas B Kipp; Victoria C Cotham; Beatrix M Ueberheide; Blake T Aftab; Mark S Anderson; Joseph L DeRisi; Michael R Wilson; Rachael J M Bashford-Rogers; Michael Platten; K Christopher Garcia; Lawrence Steinman; William H Robinson
Journal:  Nature       Date:  2022-01-24       Impact factor: 69.504

4.  High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.

Authors:  Michael Hecker; Brit Fitzner; Matthias Wendt; Peter Lorenz; Kristin Flechtner; Felix Steinbeck; Ina Schröder; Hans-Jürgen Thiesen; Uwe Klaus Zettl
Journal:  Mol Cell Proteomics       Date:  2016-02-01       Impact factor: 5.911

5.  IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, Fc-glycans and a fab-Peptide sequence.

Authors:  Susanna L Lundström; Cátia Fernandes-Cerqueira; A Jimmy Ytterberg; Elena Ossipova; Aase H Hensvold; Per-Johan Jakobsson; Vivianne Malmström; Anca I Catrina; Lars Klareskog; Karin Lundberg; Roman A Zubarev
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

6.  SpotLight Proteomics: uncovering the hidden blood proteome improves diagnostic power of proteomics.

Authors:  Susanna L Lundström; Bo Zhang; Dorothea Rutishauser; Dag Aarsland; Roman A Zubarev
Journal:  Sci Rep       Date:  2017-02-07       Impact factor: 4.379

7.  Differential tissue expression of extracellular vesicle-derived proteins in prostate cancer.

Authors:  Diederick Duijvesz; Giovanny Rodriguez-Blanco; A Marije Hoogland; Esther I Verhoef; Lennard J Dekker; Monique J Roobol; Geert J L H van Leenders; Theo M Luider; Guido Jenster
Journal:  Prostate       Date:  2019-04-24       Impact factor: 4.104

8.  Synthetic Polyclonal-Derived CDR Peptides as an Innovative Strategy in Glaucoma Therapy.

Authors:  Carsten Schmelter; Kristian Nzogang Fomo; Natarajan Perumal; Caroline Manicam; Katharina Bell; Norbert Pfeiffer; Franz H Grus
Journal:  J Clin Med       Date:  2019-08-15       Impact factor: 4.241

9.  Gray matter-related proteins are associated with childhood-onset multiple sclerosis.

Authors:  Vaibhav Singh; E Daniëlle van Pelt; Marcel P Stoop; Christoph Stingl; Immy A Ketelslegers; Rinze F Neuteboom; Coriene E Catsman-Berrevoets; Theo M Luider; Rogier Q Hintzen
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-09-24

Review 10.  Practical guidelines for B-cell receptor repertoire sequencing analysis.

Authors:  Gur Yaari; Steven H Kleinstein
Journal:  Genome Med       Date:  2015-11-20       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.